Dallas, TX -- (SBWIRE) -- 11/12/2010 -- SandlerResearch announce Rheumatoid Arthritis - Pipeline Assessment and Market Forecasts to 2017 now available at SandlerResearch
GlobalData, the industry analysis specialist, has released a new report, “Rheumatoid Arthritis - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global rheumatoid arthritis (RA) market. The report identifies the key trends shaping and driving the global RA market. The report also provides insight into the prevalent competitive landscape and the emerging players likely to affect the market positioning of the existing market leaders. Most importantly, the report provides valuable insight into the pipeline products within the global RA sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
GlobalData estimated the global RA market to be valued at $9 billion in 2009. It is forecast to grow by 6% annually for the next eight years to reach $14.3 billion by 2017.
This growth is primarily attributed to high incidence and prevalence rate, high prescription rate of drugs and a strong pipeline portfolio. GlobalData analysis indicates that the global RA market is moderately served with current product options with significant scope for new entrants to capture value from underserved segments.
Designing curable products with high safety profile is one of the key challenges of this market. Such a product is likely to result in significant market share for any company.
GlobalData analysis shows that the global RA market is becoming increasingly competitive. Balancing the pipeline with products currently marketed and the expectations of patients and physicians makes the pipeline strong. The unmet need in RA market is high and if a company has to capture this unmet need, it will have to overcome the prevailing product weaknesses and adverse effects.
Browse complete Report at : Rheumatoid Arthritis - Pipeline Assessment and Market Forecasts to 2017
Scope
The scope of the report includes:
Annualized global rheumatoid arthritis market revenue data from 2001 to 2009, forecast forward for eight years to 2017.
Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends. Key classes of mechanism of action includes Interleukin inhibitors, Kinase inhibitors, cytokine targetters, TNF targetters, C5a receptor antagonists, Cathepsin inhibitors, Histone deacetylase inhibitors (HDAC) inhibitors, Janus Kinase 3(JAK-3) inhibitors, CD4 inhibitors, p38 kinase inhibitors, Dihydrofolate Reductase inhibitors, cyclooxygenase (COX) inhibitors, Chemokine receptor antagonists, Glucocorticoid antagonists, Dihydroorotate dehydrogenase(DHODH) inhibitors, and combination therapies.
Analysis of the current and future market competition in the global rheumatoid arthritis market. Key market players covered are Pfizer Inc., Roche, Biogen Idec, Amgen Inc.,Mitsubishi Tanabe Pharma, Almirall, AnaMar Medical, Array BioPharma, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, KaloBios Pharma and GlaxoSmithKline
Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with rheumatoid arthritis.
Reasons to buy
The report will enhance your decision making capability. It will allow you to:
Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
Develop business strategies by understanding the trends shaping and driving the global rheumatoid arthritis market.
Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global rheumatoid arthritis market in future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
What’s the next big thing in the global rheumatoid arthritis market landscape? - Identify, understand and capitalize.
1 Table of contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Rheumatoid Arthritis Market: Introduction 5
2.1 GlobalData Pipeline Report Guidance 5
3 Rheumatoid Arthritis: Market Characterization 6
3.1 Overview 6
3.2 Rheumatoid Arthritis Market Size 6
3.3 Rheumatoid Arthritis Market Forecast and CAGR 7
3.4 Drivers and Barriers for the Rheumatoid Arthritis Market 8
3.4.1 Drivers for Rheumatoid Arthritis Market 8
3.4.2 Barriers for Rheumatoid Arthritis Market 8
3.5 Opportunity and Unmet Need 8
3.6 Key Takeaway 10
4 Rheumatoid Arthritis Market: Competitive Assessment 11
4.1 Overview 11
4.2 Strategic Competitor Assessment 11
4.3 Product Profile for the Major Marketed Products in the Rheumatoid Arthritis Market 12
4.3.1 Enbrel (etanercept) 12
4.3.2 Humira (adalimumab) 13
4.3.3 Remicade (infliximab) 14
4.3.4 Rituxan (rituximab) 15
4.3.5 Celebrex (celecoxib) 15
4.3.6 Orencia 16
4.4 Key Takeaway 18
5 Rheumatoid Arthritis Market: Pipeline Assessment 19
5.1 Overview 19
5.2 Strategic Pipeline Assessment 19
5.2.1 Technology Trends Analytic Framework 19
5.3 Rheumatoid Arthritis Therapeutic –Promising Drugs under Clinical Development 21
5.4 Profiles for Promising Drugs under Clinical Development for Rheumatoid Arthritis 21
5.4.1 T-614 (iguratimod) 21
5.4.2 CP-690550 22
5.4.3 Arzerra (HuMax-CD20 /Ofatumumab) 23
5.4.4 VX-509 23
5.5 Rheumatoid Arthritis Therapeutics Market – Clinical Pipeline by Mechanism of Action 25
5.6 Rheumatoid Arthritis Pipeline – Pipeline by Clinical Phases of Development 26
5.6.1 Rheumatoid Arthritis Therapeutics – Regulatory and Phase III Clinical Pipeline 26
5.6.2 Rheumatoid Arthritis – Phase II Clinical Pipeline 28
5.6.3 Rheumatoid Arthritis – Phase I Clinical Pipeline 31
5.6.4 Rheumatoid Arthritis – Preclinical Pipeline 32
5.7 Discontinued / Suspended Drugs for Rheumatoid Arthritis 35
5.8 Key Takeaway
6 Rheumatoid Arthritis Market: Implications for Future Market Competition 36
7 Rheumatoid Arthritis Market: Future Players in Rheumatoid Arthritis Market 38
7.1 Introduction 38
7.2 Pfizer 38
7.2.1 Overview 38
7.2.2 Autoimmune and Musculoskeletal Portfolio 39
7.3 Roche 39
7.3.1 Overview 39
7.3.2 Autoimmune and Musculoskeletal Portfolio 40
7.4 Amgen 41
7.4.1 Overview 41
7.4.2 Autoimmune and Musculoskeletal Portfolio 41
7.5 Biogen idec 41
7.5.1 Overview 41
7.5.2 Autoimmune and Musculoskeletal Portfolio 42
7.6 Mitsubishi Tanabe 42
7.6.1 Overview 42
7.6.2 Autoimmune and Musculoskeletal Portfolio 42
8 Rheumatoid Arthritis Market: Appendix 44
8.1 Market Definitions 44
8.2 Scope of Pipeline Research 44
8.3 Abbreviations 44
8.4 Research Methodology 45
8.4.1 Coverage 45
8.4.2 Secondary Research 46
8.4.3 Forecasting 46
8.4.4 Primary Research 49
8.4.5 Expert Panels 49
8.5 Contact Us 49
8.6 Disclaimer 49
8.7 Sources 50
ABBREVIATIONS
Browse all : Pharmaceuticals Market
http://www.sandlerresearch.org/market-research/pharmaceuticals/
Browse all : GlobalData Market
http://www.sandlerresearch.org/publishers/globaldata/
Browse all : Newly Published Market Research
http://www.sandlerresearch.org/LatestReport.aspx
Related Reports:
Pipeline Insight: Disease Modification in Rheumatoid Arthritis - New drug targets compete in crowded market
http://www.sandlerresearch.org/Reports/7854-pipeline-insight-disease-modification-in-rheumatoid-arthritis-.html
Stakeholder Insight: Rheumatoid arthritis - Rising competition by line and severity
http://www.sandlerresearch.org/Reports/34581-stakeholder-insight-rheumatoid-arthritis-rising-competition-by.html
Commercial Insight: Rheumatoid arthritis - Anti-TNFs defend first-line biologic position despite competition
http://www.sandlerresearch.org/Reports/9248-commercial-insight-rheumatoid-arthritis-anti-tnfs-defend-first.html
Global market review of automotive roof systems – forecasts to 2017
http://www.sandlerresearch.org/Reports/17319-global-market-review-of-automotive-roof-systems-forecasts-to-20.html
Global Endoscopes Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
http://www.sandlerresearch.org/Reports/25474-global-endoscopes-pipeline-analysis-opportunity-assessment-and-m.html
About Sandler Research
Sandler Research houses a comprehensive online library of more than 10,000 reports, in-depth market research studies of 5000+ micro markets, and 25 industry specific websites. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe.
Our client list boasts of many eminent publishers of such reports from across the world. As a third-party reseller of market research reports, we employ various marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques, in order to generate better revenues for our clients, entailing positive and robust results.
We also provide 24/7 online and offline support to our customers
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.sandlerresearch.org
Blog: http://sandlerresearch.blogspot.com/
Original Source: Rheumatoid Arthritis Market
http://www.sandlerresearch.org/reports/37160-rheumatoid-arthritis-pipeline-assessment-and-market-forecasts-t.html
Buy Now: Market Research
http://www.sandlerresearch.org/